Waters (WAT) Osake Kurssi
Waters Kurssi
Viimeisten 19 vuoden aikana Watersn liikevaihto kasvoi 4,9 % vuodessa ja ylsi 3,17 Mrd. USD:een. Osakekohtainen tulos on kasvanut 8,8 % vuodessa viimeisten 19 vuoden aikana. Watersn nettomarginaali 20,3 % on laskenut verrattuna 24,9 %:iin muutama vuosi sitten. Watersn 12 kuukauden konsensustavoitehinta on 420,00 USD, noin ali kurssia 1,2 %. 31 analyytikosta 20 suosittaa ostoa — kokonaiskonsensus on Osta.
Waters osakekurssi
Waters liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Waters -osakkeesta
The business model of Waters Corp is focused on the development, manufacturing, and distribution of analytical instruments and software used in the life sciences, pharmaceutical, and chemical analysis industries. Waters Corp offers a wide range of products and solutions for high-performance liquid chromatography (HPLC), mass spectrometry (MS), and thermal analysis. With a commitment to technological advancements, Waters Corp aims to provide precise and reliable solutions to its customers, enabling them to improve productivity, enhance research outcomes, and ensure regulatory compliance. By leveraging their expertise in analytical science, Waters Corp continues to be a trusted name in the industry, catering to the evolving needs of scientists and researchers worldwide.
Waters Corp is primarily active in the scientific instruments and equipment industry. As a leading provider of innovative analytical solutions, Waters Corp serves a wide range of industries including pharmaceutical, biotechnology, chemical, environmental, food and beverage, and clinical research. With its advanced technology and expertise, the company is dedicated to assisting customers in improving their productivity and making scientific discoveries. Waters Corp’s commitment to excellence and precision has established its strong presence in various sectors, making it a trusted partner for analytical solutions across multiple industries.
The main competitors of Waters Corp in the market include Agilent Technologies, PerkinElmer, Thermo Fisher Scientific, and Shimadzu Corporation.
Waters Corp is a leading company in the analytical instruments industry. Established in 1958, Waters Corp has a rich history of providing innovative solutions for chemical analysis and separations science. The company has been instrumental in developing state-of-the-art technologies that cater to the ever-evolving needs of various industries including pharmaceutical, environmental, and food & beverage. With a strong commitment to research and development, Waters Corp has continuously introduced cutting-edge products and services that drive scientific advancements. Today, Waters Corp stands as a trusted and respected name in the field, serving customers worldwide with its reliable and accurate analytical instruments.
Waters Corp has achieved several significant milestones throughout its history. Established in 1958, the company revolutionized liquid chromatography with the development of the first high-performance liquid chromatography (HPLC) system in 1971. In the following years, Waters Corp continued to innovate and pioneered various advancements in chromatography technology, including the introduction of the Acquity UPLC system in 2004. The company has also expanded globally and established a strong presence in key markets, with offices and facilities in over 50 countries. Additionally, Waters Corp has received recognition and numerous awards for its contributions to analytical science and commitment to customer satisfaction.
Waters Corp, a leading company in the stock market, primarily operates in multiple countries and regions worldwide. With a global presence, the company has established its footprint in key markets such as the United States, Europe, Asia Pacific, and Latin America. Waters Corp's extensive distribution network allows them to serve customers in diverse industries and sectors across these regions. As a result, investors can benefit from the company's broad geographical reach, which provides opportunities for growth and market expansion.
Waters Corp represents values of innovation, reliability, and customer focus. With a strong commitment to providing high-quality analytical science solutions, Waters Corp is dedicated to solving complex challenges in various industries. Their corporate philosophy revolves around empowering scientists and researchers to make groundbreaking discoveries and advancements. By leveraging cutting-edge technology and a deep understanding of customer needs, Waters Corp strives to deliver exceptional products and services. The company's culture promotes collaboration, integrity, and continuous improvement, ensuring that they remain a trusted partner and industry leader in analytical sciences.
Analyytikot asettavat tällä hetkellä Waters-osakkeelle keskimääräisen tavoitehinnan 420,64 USD (mediaani: 420,00 USD), mikä merkitsee −1,1 % viimeisimpään hintaan verrattuna. Konsensus perustuu 31 analyytikkoarvioon.
31 analyytikkoa arvioi tällä hetkellä Waters-osaketta: 20 suosittaa ostoa, 11 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Waters-yhtiöltä 6,46 Mrd. USD liikevaihtoa ja 14,56 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Waters-osake noteerataan hintaan 377,96 EUR (425,21 USD).
Waters-osake (WAT) on listattuna 7 pörssissä, muun muassa: NYSE (WAT), London (0LTI.L), SIX (Zürich) (WAZ.SW), Frankfurt (WAZ.F), München (WAZ.MU), Düsseldorf (WAZ.DU).
The Waters Corporation is an American company specializing in providing analysis equipment and software for various industries, particularly the pharmaceutical and biotechnology industries. The company was founded in 1958 and is headquartered in Milford, Massachusetts. The company's business model includes various divisions such as Life Science, Clinical, Chemical Materials, Environmental, Food, Forensic, Petrochemical, and Pharmaceutical. Each of these areas has specific requirements for analysis, and Waters Corporation offers customized solutions in each division. The company offers a variety of products, including chromatography systems, mass spectrometers, software for data analysis, and metabolite determination. The company has thousands of employees worldwide and operates branches in North America, Europe, Asia, and the Middle East. In the Life Science division, Waters Corporation offers products for the pharmaceutical industry, including a wide range of devices for quality control and drug analysis. For bioanalysis, the company provides instrumental technologies for proteomics analysis, peptide mapping, glycan analysis, and metabolic pathways. The Clinical division focuses on clinical laboratories and offers advanced chromatography and spectrometer systems that enable rapid and accurate diagnosis. Similarly, the Petrochemical division provides a wide range of analysis equipment for the petrochemical industry to test oil and gas products. The Chemical Materials division specializes in the development of materials and offers various analysis systems to monitor the quality and performance of materials. The Environmental division is responsible for the analysis of environmental samples to assess contamination in food and water sources. The Food division specializes in quality control of food and offers analysis equipment to examine the composition, nutrient content, contaminants, and allergens in food. Forensics supports justice authorities in investigating crime scenes and analyzing evidence through instruments for chemical analysis. In summary, Waters Corporation's business is focused on providing customized solutions for specific requirements in various industries. The combination of instruments and software for data analysis allows the company to deliver innovative products and services, ensuring high customer satisfaction.
odotettu liikevaihto Waters on 6,46 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Waters on 870,10 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Waters:n hinta-voitto-suhde (P/E) on tällä hetkellä 29,21. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Waters-osakkeen arvostusta.
Waters:n hinta-myynti-suhde (P/S) on tällä hetkellä 3,94. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Waters-osakkeen arvostuskennuslukuna.
Waters:n Eulpool-laatuscore on 4/10.
Waters:n ISIN on US9418481035. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Waters:n WKN on 898123. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Waters:n ticker on WAT. Tämä pörssinoteeraus käytetään Waters-osakkeiden kauppaan pörssissä.
Waters osake
Waters vertaisryhmä
Waters Ticker
Waters FIGI
Kaikki tunnusluvut ja syvällinen analyysi Waters:sta
Meidän osakeanalyysimme Waters-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Waters:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: